SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-18-002562
Filing Date
2018-02-14
Accepted
2018-02-14 15:53:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 dffn20180214_424b3.htm 424B3 461862
2 dffn20180205_s3.jpg GRAPHIC 10123
  Complete submission text file 0001437749-18-002562.txt   477222
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-222879 | Film No.: 18612025
SIC: 2834 Pharmaceutical Preparations